{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:03:41Z","timestamp":1776128621297,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T00:00:00Z","timestamp":1277769600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cardiac toxicity due to ingestion of oleander plant seeds in Sri Lanka and some other South Asian countries is very common. At present symptomatic oleander seed poisoning carries a mortality of 10% in Sri Lanka and treatment of yellow oleander poisoning is limited to gastric decontamination and atropine administration. The only proven effective antidote is digoxin antibodies but these are not available for routine use because of the high cost. The main objective of this study is to investigate the effectiveness of a new and inexpensive antidote for patients with life threatening arrhythmias due oleander poisoning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method\/design<\/jats:title>\n            <jats:p>We set up a randomised double blind clinical trial to assess the effectiveness of Fructose 1, 6 diphosphate (FDP) in acute yellow oleander poisoning patients admitted to the adult medical wards of a tertiary hospital in Sri Lanka. Patients will be initially resuscitated following the national guidelines and eligible patients will be randomised to receive either FDP or an equal amount of normal saline. The primary outcome measure for this study is the sustained reversion to sinus rhythm with a heart rate greater than 50\/min within 2 hours of completion of FDP\/placebo bolus. Secondary outcomes include death, reversal of hyperkalaemia on the 6, 12, 18 and 24 hour samples and maintenance of sinus rhythm on the holter monitor. Analysis will be on intention-to-treat.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This trial will provide information on the effectiveness of FDP in yellow oleander poisoning. If FDP is effective in cardiac glycoside toxicity, it would provide substantial benefit to the patients in rural Asia. The drug is inexpensive and thus could be made available at primary care hospitals if proven to be effective.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration<\/jats:title>\n            <jats:p>Current Controlled trial ISRCTN71018309<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-227x-10-15","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T15:59:59Z","timestamp":1335887999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fructose-1, 6-diphosphate (FDP) as a novel antidote for yellow oleander-induced cardiac toxicity: A randomized controlled double blind study"],"prefix":"10.1186","volume":"10","author":[{"given":"Indika","family":"Gawarammana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J","family":"Bowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashoka","family":"Rathnathilake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantha K","family":"Narangoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifa","family":"Azher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick A","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"issue":"4","key":"108_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1365-3156.1999.00397.x","volume":"4","author":"M Eddleston","year":"1999","unstructured":"Eddleston M, Ariaratnam CA, Meyer WP, Perera G, Kularatne AM, Attapattu S, Sheriff MH, Warrell DA: Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Trop Med Int Health. 1999, 4 (4): 266-273. 10.1046\/j.1365-3156.1999.00397.x.","journal-title":"Trop Med Int Health"},{"issue":"10","key":"108_CR2","first-page":"407","volume":"97","author":"TK Bose","year":"1999","unstructured":"Bose TK, Basu RK, Biswas B, De JN, Majumdar BC, Datta S: Cardiovascular effects of yellow oleander ingestion. J Indian Med Assoc. 1999, 97 (10): 407-410.","journal-title":"J Indian Med Assoc"},{"issue":"7151","key":"108_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmj.317.7151.133","volume":"317","author":"M Eddleston","year":"1998","unstructured":"Eddleston M, Sheriff MH, Hawton K: Deliberate self harm in Sri Lanka: an overlooked tragedy in the developing world. BMJ. 1998, 317 (7151): 133-135.","journal-title":"BMJ"},{"issue":"6","key":"108_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1540-8167.1997.tb01834.x","volume":"8","author":"AJ Levi","year":"1997","unstructured":"Levi AJ, Dalton GR, Hancox JC, Mitcheson JS, Issberner J, Bates JA, Evans SJ, Howarth FC, Hobai IA, Jones JV: Role of intracellular sodium overload in the genesis of cardiac arrhythmias. J Cardiovasc Electrophysiol. 1997, 8 (6): 700-721. 10.1111\/j.1540-8167.1997.tb01834.x.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"108_CR5","doi-asserted-by":"crossref","first-page":"H2654","DOI":"10.1152\/ajpheart.2001.281.6.H2654","volume":"281","author":"CD Hardin","year":"2001","unstructured":"Hardin CD, Lazzarino G, Tavazzi B, Di Pierro D, Roberts TM, Giardina B, Rovetto MJ: Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter. Am J Physiol Heart Circ Physiol. 2001, 281 (6): H2654-2660.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"108_CR6","first-page":"516","volume":"102","author":"FM Lu","year":"1989","unstructured":"Lu FM, Lin SY: Effects of FDP and Danshen on renal cortical Na-K-ATPase activity in rats after treatment with renal ischemia and gentamicin. Chin Med J (Engl). 1989, 102 (7): 516-523.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"108_CR7","first-page":"9","volume":"41","author":"AK Markov","year":"1999","unstructured":"Markov AK, Payment MF, Hume AS, Rao MR, Markov MA, Skelton TN, Lehan PH: Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs. Vet Hum Toxicol. 1999, 41 (1): 9-15.","journal-title":"Vet Hum Toxicol"},{"issue":"2","key":"108_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cbf.290070203","volume":"7","author":"L Galzigna","year":"1989","unstructured":"Galzigna L, Rizzoli V, Bianchi M, Rigobello MP, Scuri R: Some effects of fructose-1,6-diphosphate on rat myocardial tissue related to a membrane-stabilizing action. Cell Biochem Funct. 1989, 7 (2): 91-96. 10.1002\/cbf.290070203.","journal-title":"Cell Biochem Funct"},{"issue":"3","key":"108_CR9","first-page":"218","volume":"4","author":"M Fahim","year":"2008","unstructured":"Fahim M, Perera P, Gawarammana I, Jayamanne S, Karunathilake H, Abeysinghe C, Buckley N, Dawson A: A dose escalation study to determine the safety and efficacy of fructose 1, 6 diphosphate in treating yellow oleander poisoning. Journal of Medical Toxicology. 2008, 4 (3): 218-219.","journal-title":"Journal of Medical Toxicology"},{"issue":"5","key":"108_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0002-8703(97)70149-2","volume":"133","author":"AK Markov","year":"1997","unstructured":"Markov AK, Brumley MA, Figueroa A, Skelton TN, Lehan PH: Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function. Am Heart J. 1997, 133 (5): 541-549. 10.1016\/S0002-8703(97)70149-2.","journal-title":"Am Heart J"},{"issue":"4","key":"108_CR11","first-page":"249","volume":"5","author":"P Ripari","year":"1988","unstructured":"Ripari P, Pieralisi G: Effects of fructose-1,6-diphosphate on heart rate, ventilation, oxygen consumption and endurance performance. Pharmatherapeutica. 1988, 5 (4): 249-255.","journal-title":"Pharmatherapeutica"},{"issue":"1","key":"108_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1213\/01.ANE.0000094336.97693.90","volume":"98","author":"BJ Riedel","year":"2004","unstructured":"Riedel BJ, Gal J, Ellis G, Marangos PJ, Fox AW, Royston D: Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial. Anesth Analg. 2004, 98 (1): 20-29. 10.1213\/01.ANE.0000094336.97693.90. table of contents","journal-title":"Anesth Analg"},{"issue":"4","key":"108_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-2007-1024803","volume":"11","author":"J Myers","year":"1990","unstructured":"Myers J, Atwood JE, Forbes S, Evans B, Froelicher V: Effect of fructose 1,6-diphosphate on exercise capacity in patients with peripheral vascular disease. Int J Sports Med. 1990, 11 (4): 259-262. 10.1055\/s-2007-1024803.","journal-title":"Int J Sports Med"},{"key":"108_CR14","unstructured":"Esafosfina Italian Product Information. [http:\/\/www.torrinomedica.it\/studio\/schedefarmaci\/ESAFOSFINA.htm]"},{"issue":"9263","key":"108_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","volume":"357","author":"D Moher","year":"2001","unstructured":"Moher D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001, 357 (9263): 1191-1194. 10.1016\/S0140-6736(00)04337-3.","journal-title":"Lancet"},{"key":"108_CR16","volume-title":"Colombo","author":"R Fernando","year":"2007","unstructured":"Fernando R: Management of Poisoning: The national poisons information centre, National Hospital of Sri Lanka. Colombo. 2007"},{"key":"108_CR17","volume-title":"Marcel Dekker","author":"LD Fisher","year":"1990","unstructured":"Fisher LD, Dixon DO, Herson J, Frankowski RF, Hearron MS, Peace KE: Intention-to-Treat in Clinical Trials. Marcel Dekker. 1990"},{"key":"108_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0140-6736(00)90014-X","volume":"355","author":"M Eddleston","year":"2000","unstructured":"Eddleston M, Rajapakse S, Rajakanthan K, Jayalath S, Sj\u00f6str\u00f6m L, Santharaj W, Thenabadu P, Sheriff M, Warrell D: Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander:a randomised controlled trial. The Lancet. 2000, 355: 967-972. 10.1016\/S0140-6736(00)90014-X.","journal-title":"The Lancet"},{"issue":"3","key":"108_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/15563650902824001","volume":"47","author":"S Rajapakse","year":"2009","unstructured":"Rajapakse S: Management of yellow oleander poisoning. Clinical Toxicology. 2009, 47 (3): 206-212. 10.1080\/15563650902824001.","journal-title":"Clinical Toxicology"},{"issue":"9389","key":"108_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(03)14415-7","volume":"362","author":"M Eddleston","year":"2003","unstructured":"Eddleston M, Senarathna L, Mohamed F, Buckley N, Juszczak E, Sheriff MH, Ariaratnam A, Rajapakse S, Warrell D, Rajakanthan K: Deaths due to absence of an affordable antitoxin for plant poisoning. Lancet. 2003, 362 (9389): 1041-1044. 10.1016\/S0140-6736(03)14415-7.","journal-title":"Lancet"},{"issue":"9373","key":"108_CR21","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/S0140-6736(03)13581-7","volume":"361","author":"HA de Silva","year":"2003","unstructured":"de Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake GA, Gunatilake SB, Ranasinha CD, Lalloo DG, Aronson JK, de Silva HJ: Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003, 361 (9373): 1935-1938. 10.1016\/S0140-6736(03)13581-7.","journal-title":"Lancet"},{"issue":"9612","key":"108_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(08)60270-6","volume":"371","author":"M Eddleston","year":"2008","unstructured":"Eddleston M, Juszczak E, Buckley NA, Senarathna L, Mohamed F, Dissanayake W, Hittarage A, Azher S, Jeganathan K, Jayamanne S, et al: Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet. 2008, 371 (9612): 579-587. 10.1016\/S0140-6736(08)60270-6.","journal-title":"Lancet"},{"issue":"10","key":"108_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM200003093421006","volume":"342","author":"JM Mangrum","year":"2000","unstructured":"Mangrum JM, DiMarco JP: The evaluation and management of bradycardia. N Engl J Med. 2000, 342 (10): 703-709. 10.1056\/NEJM200003093421006.","journal-title":"N Engl J Med"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-10-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-227X-10-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-10-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-10-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T03:51:28Z","timestamp":1630468288000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcemergmed.biomedcentral.com\/articles\/10.1186\/1471-227X-10-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1186\/1471-227x-10-15","relation":{},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,29]]},"assertion":[{"value":"2 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}